Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
ITF Hellas is the Greek subsidiary of the Italfarmaco Group, a prominent Italian multinational pharmaceutical company. Founded in 1998 and headquartered in Athens, the company specializes in the commercialization and distribution of innovative pharmaceutical products and high-quality food supplements. Its core therapeutic focus areas include gynecology, neurology, endocrinology, and hematology, with a particularly strong reputation in women's health and fertility. ITF Hellas serves as a vital link for bringing Italfarmaco's global R&D advancements, such as treatments for rare diseases, to the Greek healthcare market. The company is committed to improving patient quality of life through a portfolio that balances established prescription medicines with specialized nutritional solutions.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on ITF Hellas.